Abstract
Malignant pleural mesothelioma is a rare tumour, but its incidence is increasing. Imaging is invariably involved in its diagnosis, staging, and follow-up. Although there are some characteristic radiological signs, none are pathognomonic. Computed tomography (CT) and magnetic resonance (MR) have similar local staging accuracies, but have distinct limitations; MR has marginal superiority in specific areas and should probably be offered to surgical candidates. The capabilities of multidector CT await evaluation. The role of positron emission tomography (PET), and PET-CT is undefined, but will likely have a major contribution. The challenges in imaging are matched by controversies in staging and treatment, which require future close multidisciplinary and multicentre collaboration.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 139-145 |
| Number of pages | 7 |
| Journal | Cancer Imaging |
| Volume | 3 |
| Issue number | 2 |
| DOIs | |
| State | Published - 2003 |
Keywords
- CT
- Imaging
- MRI
- Malignant pleural mesothelioma
- PET
- Staging
ASJC Scopus subject areas
- Radiological and Ultrasound Technology
- Oncology
- Radiology Nuclear Medicine and imaging
Fingerprint
Dive into the research topics of 'The role of imaging in the management of primary pleural malignancies'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS